GRIPAP1 Antikörper (Internal Region)
Kurzübersicht für GRIPAP1 Antikörper (Internal Region) (ABIN2799664)
Target
Alle GRIPAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 311-401, Internal Region
-
Verwendungszweck
- GRASP1 antibody [N3], Internal, 0.67 mg/ml
-
Immunogen
- Synthetic peptide corresponding to a region within amino acids 311-401 of GRASP1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Tested Western blot
Application Notes
Suggested starting dilutions are as follows: WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.Sample (30 μg of whole cell lysate) A: HepG2 7.5 % SDS PAGE 107-10102 diluted at 1:500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.67 mg/mL
-
Buffer
- 0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- GRIPAP1 (GRIP1 Associated Protein 1 (GRIPAP1))
-
Andere Bezeichnung
- GRASP1
-
Molekulargewicht
- 96 kDa
-
Gen-ID
- 56850
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-